Litigation Details for Boehringer Ingelheim Pharmaceuticals Inc. v. Mylan Pharmaceuticals Inc. (N.D.W. Va. 2020)

Boehringer Ingelheim Pharmaceuticals Inc. v. Mylan Pharmaceuticals Inc. (N.D.W. Va. 2020)

Docket		Date Filed	2020-02-05
Court	District Court, N.D. West Virginia	Date Terminated
Cause	35:271 Patent Infringement	Assigned To	Thomas Shawn Kleeh
Jury Demand	None	Referred To
Parties	BOEHRINGER INGELHEIM PHARMACEUTICALS INC.
Patents	10,022,379; 10,034,877; 8,853,156; 9,415,016; 9,486,526
Attorneys	Thomas F. Fleming
Firms	Katten Muchin Rosenman LLP NC
Link to Docket	External link to docket

Details for Boehringer Ingelheim Pharmaceuticals Inc. v. Mylan Pharmaceuticals Inc. (N.D.W. Va. 2020)

Date Filed	Document No.	Description	Snippet	Link To Document
0000-00-00				External link to document
2021-07-08	160	Order (PUBLIC) AND Memorandum & Opinion	the ’526 patent, U.S. Patent No. 9,415,016 (“the ’016 patent”), and U.S. Patent No. 10,022,379 (“the ’…U.S. Patent No. 8,853,156 (Dkt. No. 72-10 at 2). U.S. Patent No. 10,034,877 (“the ’877 patent”) is a …the ’526 patent, (Dkt. Nos. 72, 73), the 3 The ’016 patent and the ’379 patent concern …the ’877 patent is instructive because that patent is a continuation of the ’526 patent and the two…CONSTRUCTION This patent infringement case involves three United States Patents issued to Boehringer	External link to document
2023-10-23	220	Certificate of Service	Associated with ANDA No. 208431 for U.S. Patents Nos. 9,415,016 and 10,022,379 (Companion, James) (Entered: 10/…Product Associated with ANDA No. 208431 for U.S. Patent No. 9,486,526 and Against Mylan for its ANDA Product… 5 February 2020 1:20-cv-00019 830 Patent None District Court, N.D. West Virginia	External link to document
2020-09-30	64	Certificate of Service	Preliminary Noninfringement Contentions for U.S. Patent No. 9,486,526. (Pizzo, John) (Entered: 09/30/2020) … 5 February 2020 1:20-cv-00019 830 Patent None District Court, N.D. West Virginia	External link to document